Stockreport

This Biotech Stock Just Blew Into A Profit-Taking Zone — Here's Why [Investor's Business Daily]

Exelixis, Inc.  (EXEL) 
Last exelixis, inc. earnings: 2/25 04:05 pm Check Earnings Report
PDF Exelixis stock rocketed Monday after the biotech company's Bristol Myers Squibb-partnered kidney cancer treatment succeeded in a Phase 3 test. The duo tested Cabometyx p [Read more]